Gilead Sciences Partners with the International AIDS Society to Champion Stigma-free HIV Care Services in Asia and Latin America
SINGAPORE, Oct. 13, 2021 /PRNewswire/ -- Gilead Sciences, Inc. today announced its partnership with IAS - the International AIDS Society - to expand the Me & My Healthcare Provider campaign to three locations in Asia: Hong Kong; South Korea; and Taiwan and renew the program in two locations in Latin America: Brazil and Mexico. The campaign promotes best practices in...
New Dymax MD(R) 1040-M Autoclave Resistant Adhesive for Medical Instruments and Assembly
SINGAPORE, Oct. 13, 2021 /PRNewswire/ -- Dymax Corporation, leading manufacturer of rapid curing materials and equipment, unveils its newest product, 1040-M, as part of its MD® line of adhesives for medical device assembly applications. Designed to be autoclave resistant for more than 100 cycles, MD® 1040-M offers extremely low water absorption (0.5%) making it ideal for surgical tools and...
FII Institute partners with global entities for 5th Anniversary FII
- The Future Investment Initiative (FII) Institute has announced 16 partnerships with Saudi and international companies and entities for the 5th Anniversary of FII on October 26 – 28, 2021 - Global partners include BNY Mellon, HSBC, Reliance Industries and Softbank Vision Fund RIYADH, Saudi Arabia, Oct. 13, 2021 /PRNewswire/ -- The Future Investment Initiative (FII) Institute is...
SOPHiA GENETICS offers new genomic application for a deeper investigation of Mendelian diseases
SOPHiA Clinical Exome Solution v3 offers a streamlined end-to-end workflow to facilitate the assessment of challenging Mendelian disorders BOSTON and LAUSANNE, Switzerland, Oct. 13, 2021 /PRNewswire/ -- SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced today the launch of SOPHiA Clinical Exome Solution v3, a new genomic application that offers enhanced probe...
More community healthcare needed in COVID-19 planning as chronic disease rates pressure hospitals
Allied health experts call for more community-based care models to cope with COVID surge 'Long COVID' shown to affect one in four people who catch the virus, leading to an increase in chronic disease sufferers and the need for more rehabilitation services. The UK now has two million cases of the syndrome, Australia has no plan to...
AUM Biosciences announces closing of USD $27Million in a “Series A” Round of funding to advance its clinical stage pipeline of precision and targeted cancer therapies
SINGAPORE, Oct. 13, 2021 /PRNewswire/ -- AUM Biosciences (AUM) today announced the successful completion of USD $27 million series A funding round. This will fuel AUM's vision of developing a world class biotech pipeline focused on drugging what many consider as the undruggable targets, as well as addressing the need to delay and overcome resistance to targeted drugs in...
Accelerate Innovation Towards the Future,SAB of Winhealth Pharma Formally Established
HANGZHOU, China, Oct. 12, 2021 /PRNewswire/ -- On October 12, 2021, Hong Kong Winhealth Pharma Group, (hereinafter referred to as "Winhealth Pharma") announced the formal establishment of its Scientific Advisory Board (SAB), aiming to further expand and optimize the Group's strategic layout in medical innovation, drug research & development, and other fields. With the help of SAB, Winhealth Pharma...
Vitality International – Pioneering Algorithm Calculates The Number Of Years Individuals Can Expect To Live In Good Health
- Research shows number of years people are spending in ill health is increasing, due to the rising prevalence of chronic diseases, driven by unhealthy lifestyles - Experts call for focus on healthspan, the quality of life, alongside lifespan, the quantity of life, citing significant economic and social benefits - Pioneering...
DarwinHealth Announces Scientific Collaboration with Prelude Therapeutics to Develop Novel Biomarkers for Multiple Oncology Candidates
NEW YORK, Oct. 12, 2021 /PRNewswire/ -- DarwinHealth, Inc. today announced a scientific research collaboration employing its Biomarker Enrichment Strategies for Trials (BEST platform) to elucidate novel biomarkers to guide translational trajectories for multiple oncology molecules being developed by Prelude Therapeutics. Under the collaboration, DarwinHealth will use its proprietary, quantitative, systems biology-based...
ActionIQ Expands Its CDP Offering into the Healthcare Industry
Completes HIPAA Type I Certification, Is Recertified in SOC 2 Type II Standards NEW YORK, Oct. 12, 2021 /PRNewswire/ -- ActionIQ, the leading Enterprise Customer Data Platform (CDP), today announced that it has expanded its CDP into the healthcare vertical by completing their compliance audit for Health Insurance Portability and Accountability Act...















